CorMedix (CRMD) Free Cash Flow (2016 - 2025)
CorMedix (CRMD) has disclosed Free Cash Flow for 13 consecutive years, with $92.7 million as the latest value for Q4 2025.
- Quarterly Free Cash Flow rose 1748.72% to $92.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $172.8 million through Dec 2025, up 440.59% year-over-year, with the annual reading at $172.8 million for FY2025, 440.59% up from the prior year.
- Free Cash Flow hit $92.7 million in Q4 2025 for CorMedix, up from $30.4 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $92.7 million in Q4 2025 to a low of -$17.4 million in Q1 2024.
- Historically, Free Cash Flow has averaged $3.8 million across 5 years, with a median of -$6.3 million in 2021.
- Biggest five-year swings in Free Cash Flow: tumbled 308.37% in 2021 and later soared 1748.72% in 2025.
- Year by year, Free Cash Flow stood at -$6.5 million in 2021, then rose by 3.3% to -$6.3 million in 2022, then crashed by 65.65% to -$10.4 million in 2023, then skyrocketed by 45.96% to -$5.6 million in 2024, then skyrocketed by 1748.72% to $92.7 million in 2025.
- Business Quant data shows Free Cash Flow for CRMD at $92.7 million in Q4 2025, $30.4 million in Q3 2025, and $30.0 million in Q2 2025.